TNNI3, troponin I3, cardiac type, 7137

N. diseases: 159; N. variants: 50
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease BEFREE These results suggest that the RCM-associated cTnI R145W mutation induces a permanent structural state that is similar to, but more extensive than, that induced by PKC-mediated phosphorylation of cTnI Thr-143. 27557662 2016
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease BEFREE Our study provides information regarding TNNI3 mutations underlying RCM in contrast to other causes of a similar presentation, such as constrictive pericarditis or infiltration of cardiac muscle, all with marked right-sided cardiac manifestations. 25940119 2016
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease BEFREE Dilated and hypertrophic cardiomyopathy mutations in troponin can blunt effects of protein kinase A (PKA) phosphorylation of cardiac troponin I (cTnI), decreasing myofilament Ca2+-sensitivity; however this effect has never been tested for restrictive cardiomyopathy (RCM) mutants. 25450489 2015
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease CLINVAR High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians. 22876777 2012
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 Biomarker disease GENOMICS_ENGLAND Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. 21533915 2011
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease CLINVAR Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. 21511876 2011
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 Biomarker disease GENOMICS_ENGLAND The genetics of dilated cardiomyopathy. 20186049 2010
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 Biomarker disease BEFREE The results demonstrate that myofibril hypersensitivity to Ca(2+) is a key mechanism that causes impaired relaxation in RCM cTnI mutant hearts and Ca(2+) desensitization by cTnI-ND can correct diastolic dysfunction and rescue the RCM phenotypes, suggesting that Ca(2+) desensitization in myofibrils is a therapeutic option for treatment of diastolic dysfunction without interventions directed at the systemic beta-adrenergic-PKA pathways. 20580639 2010
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 Biomarker disease BEFREE In contrast, mutations in only desmin and cardiac troponin T and I (TNNI3) have been shown to cause restrictive cardiomyopathy (RCM). 18006163 2009
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease BEFREE Cardiac troponin I (cTnI) mutations have been linked to the development of restrictive cardiomyopathy (RCM) in human patients. 17027633 2006
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease BEFREE The present study also suggests that both HCM and RCM involving cTnI mutations share a common feature of increased Ca2+ sensitivity of cardiac myofilament, but more severe change in Ca2+ sensitivity is associated with the clinical phenotype of RCM. 16288990 2005
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease CLINVAR Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences. 15698845 2005
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease CLINVAR Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. 15607392 2004
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 AlteredExpression disease BEFREE To determine if idiopathic RCM is part of the clinical expression of TNNI3 mutations, genetic investigations of the gene were performed in an additional nine unrelated RCM patients with restrictive filling patterns, bi-atrial dilatation, normal systolic function, and normal wall thickness. 12531876 2003
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease UNIPROT Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. 12531876 2003
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 GeneticVariation disease CLINVAR Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. 12860912 2003
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 CausalMutation disease CLINVAR
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)
0.800 Biomarker disease CTD_human
CUI: C0007194
Disease: Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
0.700 Biomarker disease BEFREE We focus on gene mutations in cardiac myosin binding protein-C, β-cardiac myosin heavy chain, cardiac troponin I, and cardiac troponin T, that comprise the majority of all HCM sarcomeric gene mutations. 30885674 2019
CUI: C0007194
Disease: Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
0.700 Biomarker disease BEFREE The combined measurements of serum apelin and MWT, as well as cTNI and MWT, showed higher predictive values for predicting myocardial fibrosis in patients with HCM. 31019180 2019
CUI: C0007194
Disease: Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
0.700 Biomarker disease BEFREE We sought to explore the associations between the presence of AF and circulating biomarkers reflecting cardiovascular function (N-terminal pro-brain natriuretic peptide, NT-pro BNP), endothelial function (big endothelin-1, big ET-1), inflammation (high-sensitivity C-reactive protein), and myocardial damage (cardiac troponin I, cTnI) in HCM patients with and without left ventricular outflow tract obstruction (LVOTO).In all, 375 consecutive HCM in-hospital patients were divided into an AF group (n = 90) and a sinus rhythm (SR) group (n = 285) according to their medical history and electrocardiogram results.In comparison with the SR group, peripheral concentrations of big ET-1, NT-pro BNP, and cTnI were significantly higher in patients with AF. 30626765 2019
CARDIOMYOPATHY, DILATED, 2A (disorder)
0.700 Biomarker disease GENOMICS_ENGLAND Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes. 30681346 2019
CUI: C2750091
Disease: Cardiomyopathy, Dilated, 1FF
Cardiomyopathy, Dilated, 1FF
0.700 Biomarker disease GENOMICS_ENGLAND Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes. 30681346 2019
CUI: C0007194
Disease: Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
0.700 CausalMutation disease CLINVAR Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. 27532257 2017
CUI: C0007194
Disease: Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
0.700 Biomarker disease BEFREE A high proportion of stable hypertrophic cardiomyopathy (HCM) patients have elevated serum cardiac troponin I (cTnI), but its clinical and echocardiographic determinants are unknown. 28849602 2017